image All section
image Close
Explore Categories
UnworthyAdivasi RightsCaste DiscriminationEducationEnvironment
Fact CheckGenderGood GovernanceHealthcareHuman Rights
Human-interestInclusivityLGBTQ+Mental HealthMy Story
Northeast IndiaProtest and InjusticeResponsible BusinessRural IndiaSports
SustainabilityTrendingUpliftingAgrarian DistressAgriculture
CrimeDefenceEconomicsFinanceForeign Affairs
HistoryInterviewInvestigationLawNational Security
PoliticsPublic PolicyScienceTechnologyWelfare Schemes
Small Medium Business
Explore Tags
Caste discrimination
COVID-19: Glenmark Launches Antiviral Drug Favipiravir At Rs 103 Per Tablet
Latest News
The Logical Indian Crew

COVID-19: Glenmark Launches Antiviral Drug Favipiravir At Rs 103 Per Tablet

Glenmark Pharmaceuticals on Saturday announced the launch of its antiviral drug Favipiravir, to treat mild to moderate COVID-19 cases in India. The drug will be available as a prescription-based medication for ₹103 per tablet. Backed by strong clinical evidence, the Mumbai-based firm received the...

We are an independent and public-spirited digital media platform for Indian millennials. We report news and issues that matter as well as give you the opportunity to take action.

About Us About Fact Checking Values Ownership & Funding Team Impact
Events Testimonials Grievance Redressal Ethics Policy Fact-Checking Policy Corrections Policy
Branded Sponsored Content Policy Non Partisanship Refund Policy Absolute Editorial Independence Content Submission Terms
Contact Us Pitch A story
Facebook Facebook
twitter twitter
instagram instagram
youtube youtube
linkdein linkdein
telegram telegram
© 2024 The Logical Indian. All rights reserved.
Powered By Hocalwire
Designed by 3 Minds Digital
Terms | Privacy
X